Ledger.Open graph →
SEC Form D · filed April 2, 2018

Jaguar Health, Inc

Offering
$9.2M
Sold
$9.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Jeffrey S. Johnson · New York, NYDirectorZhi S. Yang · San Francisco, CADirectorLisa Conte · SAN FRANCISCO, CAExec · Director · PromoterSteven R. King · San Francisco, CAExecJiahao S. Qui · San Francisco, CADirectorKaren S. Wright · San Francisco, CAExecJohn S. Micek, Iii · SAN FRANCISCO, CADirectorFolkert S. Kamphuis · San Francisco, CADirectorJames S. Bochnowski · SAN FRANCISCO, CADirectorMyles P. Dempsey, Sr · Bonita Springs, FLDirectorChay Lapin · Rolling Hills Estates, CADirectorBrian G. Mccoy · Wyomissing, PAExec · Director · PromoterYoung D. Kim · Naples, FLDirectorJeff Fee · Missoula, MTExecJoseph V. Pergolizzi, Jr · Naples, FLExecDwight Kay · Rolling Hills Estates, CADirectorJoseph Carrabes · Boston, MADirectorScott T. Hall · Manhattan Beach, CADirectorFrancis K. Crawford · Wyomissing, PAExec · Director · PromoterRobert R. Hahn · Wyomissing, PADirectorAfton Capital Management LLC · Charlotte, NCDirectorHank Cui · LAKEWOOD, CADirectorJeff Fluhr · LAKEWOOD, CADirectorJamie L. Mcelhone · Philadelphia, PADirectorChris Ruppel · Portland, MEDirectorJames H. Brady · Portland, MEExecDennis G. Ruppel · Portland, MEExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗